Are you Dr. Neal?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 65 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
330 Waller Ave
Suite 100
Lexington, KY 40504Phone+1 859-254-7000Fax+1 859-255-4381
Summary
- Dr. Jeffrey Neal, MD is a rheumatologist in Lexington, Kentucky. He is currently licensed to practice medicine in Kentucky, North Carolina, and West Virginia. He is affiliated with CHI Saint Joseph Health and CHI Saint Joseph Health - Saint Joseph East.
Education & Training
University of Louisville School of MedicineFellowship, Rheumatology, 1991 - 1993
Charleston Area Medical Center/CAMC Institute for Academic MedicineResidency, Internal Medicine, 1984 - 1986
West Virginia University School of MedicineClass of 1984
Certifications & Licensure
KY State Medical License 1991 - 2025
NC State Medical License 1987 - 1999
WV State Medical License 1985 - 1999- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Fellow (FACR) American College of Rheumatology
Clinical Trials
- Comparative Efficacy and Safety Study of GP2015 and Enbrel® in Patients With Rheumatoid Arthritis Start of enrollment: 2015 Feb 21
Publications & Presentations
PubMed
- 97 citationsEfficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritis.Philip J Mease, Atul A Deodhar, Désirée van der Heijde, Frank Behrens, Alan J Kivitz
Annals of the Rheumatic Diseases. 2022-06-01 - 143 citationsThe effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritisKevin L. Winthrop, Joel Silverfield, Arthur Racewicz, Jeffrey Neal, Eun Bong Lee
Annals of the Rheumatic Diseases. 2016-04-01 - 15 citationsComparative clinical efficacy and safety of the proposed biosimilar ABP 710 with infliximab reference product in patients with rheumatoid arthritisMark C. Genovese, Juan Sánchez-Bursón, MyungShin Oh, Éva Balázs, Jeffrey Neal
Arthritis Research & Therapy. 2020-03-26
Professional Memberships
- Fellow
